LYNTRIS INC
LYNX
12.06
-0.63
-4.96%
LYNTRIS INC
US · LYNX
#2986 by market cap
Listed 2026
12.06
-0.63
-4.96%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:47
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.85, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 2 years
Latest year +16.47% YoY
Margins
- Gross margin
- 29.60%
- Operating margin
- 6.38%
- Net margin
- -2.17%
Key ratios & quality
- Enterprise valuei
- 1.67B
- Altman Z-Scorei
- 2.85
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2024 | 2025 |
|---|---|---|
| Revenue | 333.96M | 388.94M |
| Gross profit | 100.35M | 115.11M |
| Selling & admin expenses | 81.96M | 77.54M |
| Research & development | -- | -- |
| Operating profit | 4.92M | 24.83M |
| Pretax profit | -29.76M | -8.92M |
| Tax | 1.25M | -460.00K |
| Net profit | -31.02M | -8.46M |
| Basic EPS | 0 | 0 |
| Diluted EPS | -0.27 | -0.07 |
| Line item | 2025-09 | 2025-12 | 2026-06 | 2026-09 |
|---|---|---|---|---|
| Revenue | 102.09M | 107.77M | -- | 194.43M |
| Gross profit | 27.63M | 35.15M | -- | 43.24M |
| Selling & admin expenses | 18.80M | 19.95M | -- | 28.34M |
| Research & development | -- | -- | -- | -- |
| Operating profit | 5.67M | 11.78M | -- | 11.09M |
| Pretax profit | -2.92M | 3.45M | -- | -2.79M |
| Tax | 555.00K | -1.27M | -- | 234.00K |
| Net profit | -3.47M | 4.72M | -- | -3.03M |
| Basic EPS | 0 | 0 | -- | 0 |
| Diluted EPS | -0.03 | 0.04 | -- | -0.03 |
Balance sheet
| Line item | 2024 | 2025 |
|---|---|---|
| Total current assets | 97.13M | 148.38M |
| Cash & ST investments | 9.86M | 19.15M |
| Inventory | 17.00M | 17.94M |
| Total assets | 413.10M | 476.51M |
| Total current liabilities | 92.02M | 100.48M |
| Short-term debt | 7.34M | 8.39M |
| Long-term debt | 249.93M | 281.11M |
| Total liabilities | 379,086,000.00 | 421,659,000.00 |
| Total equity | 34.01M | 54.85M |
| Retained earnings | -75.64M | -84.09M |
| Line item | 2025-09 | 2025-12 | 2026-06 | 2026-09 |
|---|---|---|---|---|
| Total current assets | -- | 148.38M | 182.90M | 249.80M |
| Cash & ST investments | -- | 19.15M | 29.16M | 88.37M |
| Inventory | -- | 17.94M | 24.15M | 29.38M |
| Total assets | -- | 476.51M | 516.07M | 581.63M |
| Total current liabilities | -- | 100.48M | 150.56M | 234.16M |
| Short-term debt | -- | 8.39M | 8.64M | 12.19M |
| Long-term debt | -- | 281.11M | 272.00M | 190.51M |
| Total liabilities | -- | 421,659,000.00 | 459,214,000.00 | 462,692,000.00 |
| Total equity | -- | 54.85M | 56.86M | 118.94M |
| Retained earnings | -- | -84.09M | -97.14M | -102.11M |
Cash flow
| Line item | 2024 | 2025 |
|---|---|---|
| Operating cash flow | -9.92M | -20.91M |
| Depreciation & amortization | 22.43M | 22.27M |
| Free cash flow | -18.37M | -27.66M |
| Dividends paid | -57.00K | 0 |
| Stock buybacks / issuance | 3.00M | 28.22M |
| Ending cash balance | 10.45M | 22.64M |
| Line item | 2025-09 | 2025-12 | 2026-06 | 2026-09 |
|---|---|---|---|---|
| Operating cash flow | -3.48M | -4.13M | -- | 84.04M |
| Depreciation & amortization | 5.64M | 5.88M | -- | 6.51M |
| Free cash flow | -3.83M | -7.71M | -- | 79.47M |
| Dividends paid | 0 | 22.00K | -- | 0 |
| Stock buybacks / issuance | -- | 2.95M | -- | -- |
| Ending cash balance | 14.09M | 22.64M | -- | 91.04M |
Returns & efficiency
| Line item | 2024 | 2025 |
|---|---|---|
| ROE %i | -91.20 | -19.04 |
| ROA %i | -7.51 | -1.90 |
| ROIC %i | -1.59 | 6.66 |
| 5-year avg ROE %i | -- | -- |
| EBIT margin %i | 1.47 | 6.38 |
| FCF / sales %i | -- | -- |
| Current ratioi | 1.06 | 1.48 |
| Quick ratioi | 0.76 | 1.09 |
| Debt / assetsi | 71.08 | 68.58 |
| LT debt / equityi | 841.72 | 580.48 |
| Interest coveragei | 0.14 | 0.74 |
| Revenue CAGR (3Y) %i | -- | -- |
| Net income CAGR (3Y) %i | -- | -- |
| FCF CAGR (3Y) %i | -- | -- |
| Line item | 2025-09 | 2025-12 | 2026-06 | 2026-09 |
|---|---|---|---|---|
| ROE %i | -- | -19.04 | -20.75 | -11.18 |
| ROA %i | -- | -1.90 | -2.29 | -2.29 |
| ROIC %i | -- | 6.66 | 3.80 | 4.03 |
| 5-year avg ROE %i | -- | -- | -- | -- |
| EBIT margin %i | -- | 6.38 | 4.09 | 3.03 |
| FCF / sales %i | -- | -- | 3.84 | 18.52 |
| Current ratioi | -- | 1.48 | 1.21 | 1.07 |
| Quick ratioi | -- | 1.09 | 0.85 | 0.86 |
| Debt / assetsi | -- | 68.58 | 61.37 | 40.92 |
| LT debt / equityi | -- | 580.48 | 541.83 | 189.83 |
| Interest coveragei | -- | 0.74 | 0.55 | 0.52 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-11-20 19:47:42 · For reference only, not investment advice and not tailored to your situation.
LYNTRIS INC discussion 0 comments